Table 4 Marginal effect estimates of health care expenditures in patients with arterial hypertension according to adherence to treatment and level of physical activity in a crude analyse
Marginal effects (US$) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Consultation | Laboratory tests | Medication | Total primary care | Total sec. and terc. care | ||||||
Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | Estim. (S.E.) | [95% CI] | |
NOR + ACTIVE (reference) (n = 30) | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
NOR + IA (n = 72) | 6.0 (4.3) | -2.5; 14.6 | -2.6 (2.2) | -7.0; 1.6 | 7.5 (4.7) | -1..8; 16.9 | 10.8 (7.8) | -4.5; 26.3 | -5.7 (181.9) | -362.3; 350.7 |
AHNOTADH+ACTIVE (n = 137) | 24.0** (4.9) | 14.3; 14.3 | .8 (2.3) | -3.6; 5.4 | 42.9** (7.7) | 27.7 58.2 | 67.8** (10.0) | 48.2; 87.4 | 287.4 (189.4) | -83.8; 658.7 |
AHNOTADH+IA (n = 43) | 18.0** (6.4) | 5.3; 30.6 | 4.0 (3.3) | -2.5; 10.6 | 23.3** (8.7) | 6.2; 40.5 | 45.4** (12.7) | 20.5; 70.4 | 156.1 (226.2) | -287.3; 599.6 |
AHADH+IA (n = 16) | 28.0** (12.0) | 4.4; 51.7 | − .8 (3.2) | -7.1; 5.4 | 51.0** (23.8) | 4.3; 97.8 | 78.3** (26.3) | 26.7; 129.9 | 268.0 (352.8) | -423.5; 959.7 |
AHADH+ACTIVE (n = 8) | 17.1 (12.9) | -8.2; 42.4 | -5.3 (2.2)* | -9.8; -0.8 | 1.3 (7.8) | -14.0; 16.7 | 13.0 (16.9) | -20.1; 46.3 | 62.5 (366.1) | -655.1; 780.1 |